CAS: 1190307-88-0 melting Point :122-124 ° C density :1.41 storage conditions: Hygroscopic, -20°C Freezer, Under inert atmosphere solubility: soluble in DMSO (a little), methanol (a little) acidity coefficient (pKa) :9.39±0.10(Predicted) form :solid
use:Sofebuvir is a prodrug that can be metabolized into the active antiviral drug 2' -deoxy-2 '-α -fluorine -β -C-methyluridine 5' -monophosphate. Currently, it is in phase 3 clinical trials for the treatment of hepatitis C. Studies have shown that sofibuvir is a nucleotide inhibitor of hepatitis C virus and has a selective inhibitory effect on HCV NS5B polymerase.
0.00
0.00
CAS: 1190307-88-0 melting Point :122-124 ° C density :1.41 storage conditions: Hygroscopic, -20°C Freezer, Under inert atmosphere solubility: soluble in DMSO (a little), methanol (a little) acidity coefficient (pKa) :9.39±0.10(Predicted) form :solid
use:Sofebuvir is a prodrug that can be metabolized into the active antiviral drug 2' -deoxy-2 '-α -fluorine -β -C-methyluridine 5' -monophosphate. Currently, it is in phase 3 clinical trials for the treatment of hepatitis C. Studies have shown that sofibuvir is a nucleotide inhibitor of hepatitis C virus and has a selective inhibitory effect on HCV NS5B polymerase.